CorMedix IncNASDAQ:CRMD
- LAST PRICE4.7200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.5100/ 1
- Ask / Lots5.1000/ 2
- Open / Previous Close0.0000 / 4.7200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 21824 | 4.74 |
| 09:34 ET | 2600 | 4.765 |
| 09:36 ET | 9960 | 4.7695 |
| 09:38 ET | 1501 | 4.76 |
| 09:39 ET | 1285 | 4.78 |
| 09:41 ET | 300 | 4.785 |
| 09:43 ET | 1100 | 4.795 |
| 09:45 ET | 364 | 4.79 |
| 09:48 ET | 791 | 4.795 |
| 09:50 ET | 3000 | 4.78 |
| 09:52 ET | 100 | 4.76 |
| 09:54 ET | 2700 | 4.74 |
| 09:56 ET | 100 | 4.77 |
| 09:59 ET | 200 | 4.75 |
| 10:01 ET | 301 | 4.75 |
| 10:03 ET | 1600 | 4.75 |
| 10:06 ET | 151 | 4.75 |
| 10:08 ET | 6600 | 4.76 |
| 10:10 ET | 3206 | 4.7699 |
| 10:12 ET | 600 | 4.76 |
| 10:14 ET | 2405 | 4.76 |
| 10:17 ET | 208 | 4.78 |
| 10:19 ET | 2100 | 4.7803 |
| 10:21 ET | 100 | 4.785 |
| 10:24 ET | 100 | 4.78 |
| 10:26 ET | 100 | 4.775 |
| 10:30 ET | 1306 | 4.77 |
| 10:33 ET | 1300 | 4.7447 |
| 10:35 ET | 6087 | 4.72 |
| 10:37 ET | 6100 | 4.695 |
| 10:39 ET | 100 | 4.695 |
| 10:42 ET | 1300 | 4.69 |
| 10:46 ET | 500 | 4.71 |
| 10:48 ET | 8000 | 4.715 |
| 10:50 ET | 1000 | 4.7199 |
| 10:51 ET | 3171 | 4.7202 |
| 10:53 ET | 17663 | 4.715 |
| 10:55 ET | 700 | 4.72 |
| 10:57 ET | 1200 | 4.735 |
| 11:00 ET | 998 | 4.74 |
| 11:02 ET | 400 | 4.735 |
| 11:04 ET | 550 | 4.725 |
| 11:06 ET | 2790 | 4.7201 |
| 11:08 ET | 200 | 4.725 |
| 11:09 ET | 8100 | 4.72 |
| 11:11 ET | 400 | 4.71 |
| 11:13 ET | 200 | 4.71 |
| 11:18 ET | 1570 | 4.7026 |
| 11:22 ET | 1200 | 4.705 |
| 11:24 ET | 1000 | 4.7099 |
| 11:26 ET | 100 | 4.7099 |
| 11:27 ET | 1100 | 4.705 |
| 11:29 ET | 500 | 4.71 |
| 11:31 ET | 1980 | 4.7099 |
| 11:33 ET | 1249 | 4.71 |
| 11:36 ET | 1396 | 4.7 |
| 11:38 ET | 1691 | 4.71 |
| 11:40 ET | 590 | 4.71 |
| 11:42 ET | 979 | 4.69 |
| 11:44 ET | 6990 | 4.67 |
| 11:45 ET | 8639 | 4.69 |
| 11:47 ET | 7190 | 4.69 |
| 11:49 ET | 100 | 4.6913 |
| 11:51 ET | 1501 | 4.6878 |
| 11:54 ET | 2100 | 4.6801 |
| 11:58 ET | 1150 | 4.685 |
| 12:00 ET | 200 | 4.685 |
| 12:02 ET | 200 | 4.685 |
| 12:05 ET | 6625 | 4.6718 |
| 12:12 ET | 899 | 4.68 |
| 12:14 ET | 100 | 4.685 |
| 12:18 ET | 100 | 4.685 |
| 12:20 ET | 100 | 4.685 |
| 12:21 ET | 100 | 4.685 |
| 12:23 ET | 2193 | 4.69 |
| 12:25 ET | 2650 | 4.684 |
| 12:27 ET | 100 | 4.683 |
| 12:30 ET | 1000 | 4.681 |
| 12:32 ET | 5048 | 4.635 |
| 12:34 ET | 3800 | 4.66 |
| 12:36 ET | 2013 | 4.66 |
| 12:38 ET | 100 | 4.665 |
| 12:39 ET | 800 | 4.6656 |
| 12:41 ET | 400 | 4.671 |
| 12:43 ET | 1400 | 4.6703 |
| 12:45 ET | 200 | 4.67 |
| 12:48 ET | 500 | 4.66 |
| 12:50 ET | 900 | 4.67 |
| 12:52 ET | 25915 | 4.655 |
| 12:56 ET | 4954 | 4.6499 |
| 12:59 ET | 1135 | 4.6536 |
| 01:01 ET | 1670 | 4.655 |
| 01:06 ET | 1440 | 4.6571 |
| 01:08 ET | 400 | 4.655 |
| 01:10 ET | 1971 | 4.66 |
| 01:14 ET | 1282 | 4.66 |
| 01:15 ET | 100 | 4.665 |
| 01:19 ET | 1100 | 4.6685 |
| 01:21 ET | 2604 | 4.6799 |
| 01:26 ET | 200 | 4.67 |
| 01:28 ET | 3513 | 4.67 |
| 01:30 ET | 230 | 4.6726 |
| 01:32 ET | 400 | 4.665 |
| 01:33 ET | 526 | 4.67 |
| 01:35 ET | 526 | 4.67 |
| 01:37 ET | 1907 | 4.6787 |
| 01:39 ET | 1806 | 4.66 |
| 01:44 ET | 874 | 4.655 |
| 01:46 ET | 100 | 4.655 |
| 01:48 ET | 282 | 4.655 |
| 01:50 ET | 1481 | 4.655 |
| 01:51 ET | 600 | 4.66 |
| 01:53 ET | 100 | 4.65 |
| 01:55 ET | 2000 | 4.65 |
| 01:57 ET | 4400 | 4.64 |
| 02:00 ET | 1236 | 4.64 |
| 02:04 ET | 200 | 4.635 |
| 02:06 ET | 300 | 4.635 |
| 02:08 ET | 1000 | 4.64 |
| 02:09 ET | 800 | 4.64 |
| 02:11 ET | 11720 | 4.675 |
| 02:13 ET | 200 | 4.675 |
| 02:15 ET | 100 | 4.68 |
| 02:18 ET | 110 | 4.675 |
| 02:20 ET | 100 | 4.675 |
| 02:24 ET | 200 | 4.675 |
| 02:26 ET | 100 | 4.675 |
| 02:31 ET | 2399 | 4.675 |
| 02:33 ET | 946 | 4.665 |
| 02:36 ET | 635 | 4.675 |
| 02:38 ET | 757 | 4.67 |
| 02:44 ET | 1093 | 4.66 |
| 02:45 ET | 200 | 4.655 |
| 02:47 ET | 300 | 4.655 |
| 02:49 ET | 453 | 4.655 |
| 02:51 ET | 2700 | 4.655 |
| 02:54 ET | 300 | 4.66 |
| 02:56 ET | 124 | 4.655 |
| 02:58 ET | 1218 | 4.65 |
| 03:00 ET | 1123 | 4.67 |
| 03:02 ET | 300 | 4.67 |
| 03:03 ET | 100 | 4.68 |
| 03:09 ET | 100 | 4.6899 |
| 03:12 ET | 1667 | 4.675 |
| 03:14 ET | 21069 | 4.64 |
| 03:16 ET | 3354 | 4.66 |
| 03:18 ET | 1189 | 4.655 |
| 03:20 ET | 4355 | 4.66 |
| 03:21 ET | 2882 | 4.675 |
| 03:23 ET | 335 | 4.675 |
| 03:25 ET | 8383 | 4.68 |
| 03:27 ET | 4099 | 4.67 |
| 03:30 ET | 728 | 4.675 |
| 03:32 ET | 1100 | 4.68 |
| 03:34 ET | 19639 | 4.71 |
| 03:36 ET | 1400 | 4.705 |
| 03:38 ET | 13351 | 4.735 |
| 03:39 ET | 350 | 4.735 |
| 03:41 ET | 17145 | 4.74 |
| 03:43 ET | 200 | 4.74 |
| 03:45 ET | 100 | 4.735 |
| 03:48 ET | 600 | 4.74 |
| 03:50 ET | 400 | 4.74 |
| 03:52 ET | 8569 | 4.75 |
| 03:54 ET | 400 | 4.75 |
| 03:56 ET | 7329 | 4.74 |
| 03:57 ET | 955 | 4.735 |
| 03:59 ET | 2218 | 4.72 |
Jun 6, 2024
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath, from 8:30AM ET on Thursday Jun 06, 2024 by Dow Jones
8:30AM ET on Thursday Jun 06, 2024 by Dow Jones
May 28, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
8:30AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 259.5M | -5.1x | --- |
Cipla Ltd | 15.1B | 0.0x | --- |
Zevra Therapeutics Inc | 194.6M | -3.5x | --- |
Calliditas Therapeutics AB | 1.2B | -20.8x | --- |
Assembly Biosciences Inc | 84.8M | -1.4x | --- |
Incannex Healthcare Inc | 52.7M | 0.0x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $259.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.62 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
